Skip to content

Clinical trials

Terminated Phase 3 Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 3 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20042
20071
20082
20091
20171
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
AHS Cancer Control Alberta1
DelMar Pharmaceuticals, Inc.1
Isarna Therapeutics GmbH1
M.D. Anderson Cancer Center1
NRG Oncology1
National Cancer Institute (NCI)1
Sun Yat-sen University1
Tufts Medical Center1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms13
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Glioblastoma3
Glioma3
Neoplasm Metastasis3
Astrocytoma2
Fatigue2
Lung Neoplasms2
Melanoma2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.